Acute lymphoblastic leukemia
Would you like to receive a message when there is new research on Acute Lymphoblastic Leukemia? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication is one sentence explaining what was investigated — and you'll receive a message as soon as there is new research on Acute Lymphoblastic Leukemia. View what Premium costs.
Publications (1440)
- Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT. (2017/12/04) ♡
- Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia. (2017/12/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP). (2017/12/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Targeting mitochondrial respiration selectively sensitizes pediatric acute lymphoblastic leukemia cell lines and patient samples to standard chemotherapy. (2017/12/01) ♡
- Phloridzin docosahexaenoate, a novel flavonoid derivative, suppresses growth and induces apoptosis in T-cell acute lymphoblastic leukemia cells. (2017/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Image Gallery: Primary cutaneous precursor B-lymphoblastic lymphoma in an infant. (2017/12/01) ♡
- Influence of thiopurine methyltransferase gene polymorphism on Egyptian children with acute lymphoblastic leukaemia. (2017/12/01) ♡
- ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. (2017/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pseudo-Chediak-Higashi inclusions in a case of acute lymphoblastic leukemia. (2017/12/01) ♡
- Aleukemic extramedullary T lymphoid/myeloid bilineage hematopoietic and lymphoid malignancy with progression to bilineage leukemia at relapse: A case report. (2017/12/01) ♡
- Photoletter to the editor: Atypical primary cutaneous mucormycosis of the scalp. (2017/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study). (2017/12/01) ♡
- The methylenetetrahydrofolate reductase 677T-1298C haplotype is a risk factor for acute lymphoblastic leukemia in children. (2017/12/01) ♡
- Oral mucositis and saliva IgA, IgG and IgM concentration during anti-tumor treatment in children suffering from acute lymphoblastic leukemia. (2017/12/01) ♡
- Evaluation of febrile neutropenic attacks of pediatric hematology-oncology patients. (2017/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Evaluation of two non-myasthenic patients with ptosis. (2017/12/01) ♡
- Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia. (2017/12/01) ♡
- Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies. (2017/11/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation. (2017/11/28) ♡
- Blockade of CD7 expression in T cells for effective chimeric antigen receptor targeting of T-cell malignancies. (2017/11/21) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice. (2017/11/21) ♡
- Role of epigenetic regulation on the induction of apoptosis in Jurkat leukemia cells by white grape pomace rich in phenolic compounds. (2017/11/15) ♡
- Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors. (2017/11/10) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review. (2017/11/01) ♡
- Effects of malnutrition on treatment-related morbidity and survival of children with cancer in Nicaragua. (2017/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia. (2017/11/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Opportunities for targeting gene regulatory factors in B-cell acute lymphoblastic leukemia. (2017/11/01) ♡
- Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review. (2017/10/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ponatinib-induced ichthyosiform drug eruption: insights into acquired ichthyosis. (2017/10/15) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia. (2017/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Fibroblast growth factor receptor-1 associated myeloproliferative neoplasm and T-lymphoblastic lymphoma. (2017/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. CD19-negative B-lineage acute lymphoblastic leukemia: A diagnostic and therapeutic challenge. (2017/10/01) ♡
- DROSHA rs642321 Polymorphism Influence Susceptibility to Childhood Acute Lymphoblastic Leukemia: A Preliminary Report. (2017/10/01) ♡
- Screening for Type II L-Asparaginases: Lessons from the Genus Halomonas. (2017/10/01) ♡
- Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital. (2017/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Chylothorax in children with cancer: A milky predicament. (2017/10/01) ♡
- Association between SLC19A1 Gene Polymorphism and High Dose Methotrexate Toxicity in Childhood Acute Lymphoblastic Leukaemia and Non Hodgkin Malignant Lymphoma: Introducing a Haplotype based Approach. (2017/09/18) ♡
- Osteonecrosis in patients with acute lymphoblastic leukaemia: a national questionnaire study. (2017/09/11) ♡
- Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex. (2017/09/08) ♡
- Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways. (2017/09/08) ♡
- Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia. (2017/09/08) ♡
- Effect of methotrexate/vitamin B(12) on DNA methylation as a potential factor in leukemia treatment-related neurotoxicity. (2017/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Disseminated aspergillosis due to Aspergillus flavus in a pediatric patient with a recent diagnosis of acute lymphoblastic leukemia]. (2017/09/01) ♡
- Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. (2017/08/30) ♡
- Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screening. (2017/08/15) ♡
- Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia? (2017/08/14) ♡
- Parental Perceptions of Obesity and Obesity Risk Associated With Childhood Acute Lymphoblastic Leukemia. (2017/07/01) ♡
- Effectiveness of Parenteral Glutamine on Methotrexate-induced Oral Mucositis in Children with Acute Lymphoblastic Leukemia. (2017/07/01) ♡
- The Associations of Height-for-Age, Weight-for-Age, and Weight-for-Height With Pediatric Acute Lymphoblastic Leukemia. (2017/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Epigenetic alterations in acute lymphoblastic leukemia]. (2017/07/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.